| Patent | Date |
|---|
Anti-proprotein Convertase Subtilisin Kexin Type 9 (anti-pcsk9) Nano-formulation Of Compounds And Methods Of Using The Same
App 20220031665 - Mousa; Shaker A. ; et al. | 2022-02-03 |
Composition of scalable thyrointegrin antagonists with improved retention in tumors
Grant 11,186,551 - Mousa , et al. November 30, 2 | 2021-11-30 |
Environmentally natural protective and therapeutic (ENPT) face mask
Grant 11,178,923 - Mousa , et al. November 23, 2 | 2021-11-23 |
Environmentally Natural Protective And Therapeutic (enpt) Face Mask
App 20210345708 - Mousa; Shaker A. ; et al. | 2021-11-11 |
Composition Of Scalable Thyrointegrin Antagonists With Improved Retention In Tumors
App 20210340111 - Mousa; Shaker A. ; et al. | 2021-11-04 |
Method For Prevention And Treatment Of A Viral-mediated Infectious Disease
App 20210290531 - Mousa; Shaker A. | 2021-09-23 |
Method and composition for treating upper respiratory tract inflammatory and infectious diseases
Grant 10,993,909 - Mousa May 4, 2 | 2021-05-04 |
Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
Grant 10,961,204 - Mousa , et al. March 30, 2 | 2021-03-30 |
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases
Grant 10,947,220 - Abdel-Meguid , et al. March 16, 2 | 2021-03-16 |
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases
Grant 10,899,748 - Abdel-Meguid , et al. January 26, 2 | 2021-01-26 |
Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or
App 20200262822 - Abdel-Meguid; Sherin Salaheldin ; et al. | 2020-08-20 |
Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonists
Grant 10,695,436 - Mousa , et al. | 2020-06-30 |
Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or
App 20190270729 - Abdel-Meguid; Sherin Salaheldin ; et al. | 2019-09-05 |
Non-cleavable Polymer Conjugated With Alpha V Beta 3 Integrin Thyroid Antagonists
App 20190111145 - Mousa; Shaker A. ; et al. | 2019-04-18 |
Non-cleavable polymer conjugated with .alpha.V.beta.3 integrin thyroid antagonists
Grant 10,201,616 - Mousa , et al. Feb | 2019-02-12 |
Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases
Grant 10,131,637 - Abdel-Meguid , et al. November 20, 2 | 2018-11-20 |
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
Grant 10,130,686 - Mousa , et al. November 20, 2 | 2018-11-20 |
Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof
Grant 10,060,934 - Mousa , et al. August 28, 2 | 2018-08-28 |
Composition and method of use for combinations of anti-viral protease, polymerase inhibitors and natural bioactive compounds in the treatment of hepatitis C infection
Grant 10,046,005 - Mousa August 14, 2 | 2018-08-14 |
Thyroid hormone analogs and methods of use
Grant 9,980,933 - Mousa , et al. May 29, 2 | 2018-05-29 |
Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting
Grant 9,956,291 - Mousa May 1, 2 | 2018-05-01 |
Composition of nanoformulated lycopene and method of using the composition
Grant 9,956,181 - Mousa , et al. May 1, 2 | 2018-05-01 |
Composition and method for stopping hemorrhage, infection, and accelerating healing in various types of wound or burns
Grant 9,950,091 - Mousa , et al. April 24, 2 | 2018-04-24 |
Anti-pcsk9 Compounds And Methods For The Treatment And/or Prevention Of Cardiovascular Diseases
App 20180079730 - Abdel-Meguid; Sherin Salaheldin ; et al. | 2018-03-22 |
Non-cleavable Polymer Conjugated With Alpha V Beta 3 Integrin Thyroid Antagonists
App 20170348425 - Mousa; Shaker A. ; et al. | 2017-12-07 |
Compositions and method for anti-sickling of red blood cells in sickle cell disease
Grant 9,822,190 - Mousa November 21, 2 | 2017-11-21 |
Methods and compositions of camel derived products
Grant 9,770,419 - Mousa , et al. September 26, 2 | 2017-09-26 |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
Grant 9,750,709 - Mousa , et al. September 5, 2 | 2017-09-05 |
Compositions of novel bone patch in bone and vascular regeneration
Grant 9,707,318 - Mousa , et al. July 18, 2 | 2017-07-18 |
Nanoformulation of musk-derived bioactive ingredients for nanocosmetic applications
Grant 9,700,042 - Mousa , et al. July 11, 2 | 2017-07-11 |
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases
Grant 9,682,085 - Abdel-Meguid , et al. June 20, 2 | 2017-06-20 |
Ocular nanoformulation and method of use in angiogenesis-mediated disorders
Grant 9,655,862 - Mousa May 23, 2 | 2017-05-23 |
Method And Composition Of Thyroid Hormone Analogues And Nanoformulations Thereof For Treating Anti-inflammatory Disorders
App 20170080058 - Mousa; Shaker A. ; et al. | 2017-03-23 |
Nano-targeted delivery of protease, polymerase inhibitors with or without immune modulators in the treatment of hepatitis C
Grant 9,597,351 - Mousa March 21, 2 | 2017-03-21 |
Composition Of Nanoformulated Lycopene And Method Of Using The Composition
App 20170071873 - Mousa; Shaker A. ; et al. | 2017-03-16 |
Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders
Grant 9,580,395 - Mousa February 28, 2 | 2017-02-28 |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
Grant 9,579,300 - Mousa , et al. February 28, 2 | 2017-02-28 |
Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasis
Grant 9,572,831 - Mousa February 21, 2 | 2017-02-21 |
Composition And Method Of Use For Combinations Of Anti-viral Protease, Polymerase Inhibitors And Natural Bioactive Compounds In The Treatment Of Hepatitis C Infection
App 20160346308 - Mousa; Shaker A. | 2016-12-01 |
Nano Co-encapsulation For The Prevention And Treatment Of Various Disorders
App 20160338971 - Mousa; Shaker A. ; et al. | 2016-11-24 |
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
Grant 9,498,536 - Mousa , et al. November 22, 2 | 2016-11-22 |
Method and composition of glycosaminoglycans in sickle cell and vascular disorders
Grant 9,480,703 - Mousa November 1, 2 | 2016-11-01 |
Anti-proprotein Convertase Subtilisin Kexin Type 9 (anti-pcsk9) Compounds And Methods Of Using The Same In The Treatment And/or Prevention Of Cardiovascular Diseases
App 20160256467 - Abdel-Meguid; Sherin Salaheldin ; et al. | 2016-09-08 |
Functionalized Furan-2-sulfonamides Exhibiting Endothelial Lipase Inhibition
App 20160257672 - Abou-Gharbia; Magid ; et al. | 2016-09-08 |
Compositions And Method For Anti-sickling Of Red Blood Cells In Sickle Cell Disease
App 20160222137 - Mousa; Shaker A. | 2016-08-04 |
Composition And Method For Stopping Hemorrhage, Infection, And Accelerating Healing In Various Types Of Wound Or Burns
App 20160206773 - Mousa; Shaker A. ; et al. | 2016-07-21 |
Rgd-binding Compounds And Methods Of Use
App 20160178615 - ALEXANDER-BRIDGES; MARIA ; et al. | 2016-06-23 |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
Grant 9,289,395 - Davis , et al. March 22, 2 | 2016-03-22 |
Methods of stimulating fat mobilization using a polymer conjugated polyphenol
Grant 9,272,049 - Alexander-Bridges , et al. March 1, 2 | 2016-03-01 |
Anti-pcsk9 Compounds And Methods For The Treatment And/or Prevention Of Cardiovascular Diseases
App 20150376139 - Abdel-Meguid; Sherin Salaheldin ; et al. | 2015-12-31 |
Anti-proprotein Convertase Subtilisin Kexin Type 9 (anti-pcsk9) Compounds And Methods Of Using The Same In The Treatemnt And/or Prevention Of Cardiovascular Diseases
App 20150374710 - Abdel-Meguid; Sherin Salaheldin ; et al. | 2015-12-31 |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
Grant 9,220,788 - Davis , et al. December 29, 2 | 2015-12-29 |
Thyroid hormone analogs and methods of use
Grant 9,198,887 - Mousa , et al. December 1, 2 | 2015-12-01 |
Combination treatment of cancer with cetuximab and tetrac
Grant 9,180,107 - Lin , et al. November 10, 2 | 2015-11-10 |
Nanoformulation Of Musk-derived Bioactive Ingredients For Nanocosmetic Applications
App 20150223451 - Mousa; Shaker A. ; et al. | 2015-08-13 |
Nano-targeted Delivery Of Protease, Polymerase Inhibitors With Or Without Immune Modulators In The Treatment Of Hepatitis C
App 20150224134 - Mousa; Shaker A. | 2015-08-13 |
Method And Composition Of Glycosaminoglycans In Sickle Cell And Vascular Disorders
App 20150150818 - Mousa; Shaker A. | 2015-06-04 |
Methods For Screening Patients For Resistance To Angioinhibition, Treatment And Prophylaxis Thereof
App 20150139934 - MOUSA; SHAKER A. ; et al. | 2015-05-21 |
Ocular Nanoformulation And Method Of Use In Angiogenesis-mediated Disorders
App 20150140106 - Mousa; Shaker A. | 2015-05-21 |
Composition And Method For Sulfated Non-anticoagulant Low Molecular Weight Heparins In Cancer And Tumor Metastasis
App 20150132399 - Mousa; Shaker A. | 2015-05-14 |
Formulations of Factor VIIa inhibitors and utility
Grant 8,980,823 - Mousa March 17, 2 | 2015-03-17 |
Nanoformulation of vitamin D derivatives and/or vitamin D metabolites
Grant 8,968,790 - Mousa March 3, 2 | 2015-03-03 |
Compositions Of Dual Thyrointegrin Antagonists And Use In Vascular-associated Disorders
App 20150031688 - Mousa; Shaker A. | 2015-01-29 |
Nanoparticle And Polymer Formulations For Thyroid Hormone Analogs, Antagonists, And Formulations Thereof
App 20140314665 - Mousa; Shaker A. ; et al. | 2014-10-23 |
Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders
Grant 8,859,539 - Mousa October 14, 2 | 2014-10-14 |
Method And Composition Of Thyroid Hormone Analogues And Nanoformulations Thereof For Treating Anti-inflammatory Disorders
App 20140294931 - Mousa; Shaker A. ; et al. | 2014-10-02 |
Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
Grant 8,802,240 - Davis , et al. August 12, 2 | 2014-08-12 |
Nanoparticle And Polymer Formulations For Thyroid Hormone Analogs, Antagonists, And Formulations Thereof
App 20140199376 - Mousa; Shaker A. ; et al. | 2014-07-17 |
Thyroid Hormone Analogs And Methods Of Use
App 20140072635 - Mousa; Shaker A. ; et al. | 2014-03-13 |
Thyroid Hormone Analogs And Methods Of Use
App 20140072646 - Mousa; Shaker A. ; et al. | 2014-03-13 |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
Grant 8,668,926 - Mousa , et al. March 11, 2 | 2014-03-11 |
Methods And Compositions Of Camel Derived Products
App 20140037722 - Mousa; Shaker A. ; et al. | 2014-02-06 |
Nanoformulation And Methods Of Use Of Thyroid Receptor Beta1 Agonists For Liver Targeting
App 20140017329 - Mousa; Shaker A. | 2014-01-16 |
Filter composites for drug detoxification
Grant 8,607,989 - Mousa , et al. December 17, 2 | 2013-12-17 |
NOVEL FORMULATIONS OF FACTOR VIIa INHIBITORS AND UTILITY
App 20130295187 - Mousa; Shaker A. | 2013-11-07 |
Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis
Grant 8,563,053 - Mousa , et al. October 22, 2 | 2013-10-22 |
Thyroid hormone analogs and methods of use
Grant 8,518,451 - Mousa , et al. August 27, 2 | 2013-08-27 |
Formulations of factor VIIa inhibitors and utility
Grant 8,481,479 - Mousa July 9, 2 | 2013-07-09 |
Nanoformulation Of Vitamin D Derivatives And/or Vitamin D Metabolites
App 20130149385 - Mousa; Shaker A. | 2013-06-13 |
Method and system with contact lens product for treating and preventing adverse eye conditions
Grant 8,440,217 - El-Naggar , et al. May 14, 2 | 2013-05-14 |
Uses Of Formulations Of Thyroid Hormone Analogs And Nanoparticulate Forms Thereof To Increase Chemosensivity And Radiosensitivity In Tumor Or Cancer Cells
App 20120315320 - Davis; Paul J. ; et al. | 2012-12-13 |
Silver nanoparticles as anti-microbial
Grant 8,314,078 - Mousa , et al. November 20, 2 | 2012-11-20 |
Rgd-binding Compounds And Methods Of Use
App 20120258069 - Alexander-Bridges; Maria ; et al. | 2012-10-11 |
Oxidized heparin fractions and their use in inhibiting angiogenesis
Grant 8,071,569 - Mousa December 6, 2 | 2011-12-06 |
Thyroid hormone analogs and methods of use
Grant 8,071,134 - Mousa , et al. December 6, 2 | 2011-12-06 |
Oxidized Heparin Fractions And Their Use In Inhibiting Angiogenesis
App 20110200673 - Mousa; Shaker A. | 2011-08-18 |
Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof
App 20110142941 - Davis; Paul J. ; et al. | 2011-06-16 |
Compositions Of Novel Bone Patch In Bone And Vascular Regeneration
App 20110104230 - Mousa; Shaker A. ; et al. | 2011-05-05 |
Compositions And Methods Of Targeted Nanoformulations In The Management Of Osteoporosis
App 20110104265 - Mousa; Shaker A. ; et al. | 2011-05-05 |
Compositions Of Dual Thyrointegrin Antagonists And Use In Vascular-associated Disorders
App 20110105482 - Mousa; Shaker A. | 2011-05-05 |
Compositions And Methods Of Natural Products In Nanoformulations For The Prevention And Treatment Of Osteoporosis
App 20110104283 - Mousa; Shaker A. ; et al. | 2011-05-05 |
Nanoparticle And Polymer Formulations For Thyroid Hormone Analogs, Antagonists, And Formulations And Uses Thereof
App 20110052715 - Davis; Paul J. ; et al. | 2011-03-03 |
Novel Filter Composites For Drug Detoxification
App 20100316694 - Mousa; Shaker A. ; et al. | 2010-12-16 |
Silver Nanoparticles As Anti-microbial
App 20100317617 - Mousa; Shaker A. ; et al. | 2010-12-16 |
Thyroid hormone analogs and methods of use
Grant 7,785,632 - Mousa , et al. August 31, 2 | 2010-08-31 |
Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use
App 20100209382 - Alexander-Bridges; Maria ; et al. | 2010-08-19 |
Pharmaceutical Compositions Containing Pyrroloquinoline Quinone And Nephroprotectant For Treating Ischemia Reperfusion Injuries
App 20100160367 - Davis; Paul J. ; et al. | 2010-06-24 |
Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use
App 20100159021 - Davis; Paul ; et al. | 2010-06-24 |
Thyroid Hormone Analogs and Methods of Use
App 20100112079 - Mousa; Shaker A. ; et al. | 2010-05-06 |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
App 20090022806 - Mousa; Shaker A. ; et al. | 2009-01-22 |
Drug Resistance Reversal In Neoplastic Disease
App 20080200405 - Patil; Ghanshyam ; et al. | 2008-08-21 |
Thyroid Hormone Analogs and Methods of Use
App 20080124280 - Mousa; Shaker A. ; et al. | 2008-05-29 |
Pyrroloquinoline quinone drugs and methods of use thereof
App 20080051428 - Davis; Paul J. ; et al. | 2008-02-28 |
Treatment of disease with antibodies against high molecular weight kininogen domain 5
Grant 7,332,161 - Colman , et al. February 19, 2 | 2008-02-19 |
Treatment of disease with antibodies against high molecular weight kininogen domain 5
App 20060115471 - Colman; Robert W. ; et al. | 2006-06-01 |
Activators and inhibitors of protease activated receptor2 (PAR2) and methods of use
App 20060104944 - Mousa; Shaker A. | 2006-05-18 |
Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
Grant 6,994,852 - Colman , et al. February 7, 2 | 2006-02-07 |
Prevention and treatment of tumor growth, metastasis, and thromboembolic complications in cancer patients
Grant 6,908,907 - EL-Naggar , et al. June 21, 2 | 2005-06-21 |
Thyroid hormone analogs and methods of use
App 20050124862 - Mousa, Shaker A. ; et al. | 2005-06-09 |
Prevention and treatment of tumor growth, metastasis, and thromboembolic complications in cancer patients
App 20040214751 - El-Naggar, Mawaheb M. ; et al. | 2004-10-28 |
Prevention and treatment of thromboembolic disorders associated with arterial & venous thrombosis
App 20030199457 - El-Naggar, Mawaheb M. ; et al. | 2003-10-23 |
Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders
App 20020068719 - Wong, Pancras C. ; et al. | 2002-06-06 |
Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5
Grant 6,284,726 - Colman , et al. September 4, 2 | 2001-09-04 |
| 